13q deletion syndrome
A genetic disorder caused by the deletion of part of chromosome 13
| Medical genetics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This medical genetics-related article is a stub. You can help WikiMD by expanding it.
|
13q deletion syndrome is a genetic disorder caused by the deletion of a portion of the long arm (q arm) of chromosome 13. This condition can lead to a variety of developmental and physical abnormalities, depending on the size and location of the deletion.
Genetics
13q deletion syndrome is typically caused by a deletion of genetic material on the q arm of chromosome 13. The size of the deletion can vary, and larger deletions tend to result in more severe manifestations of the syndrome. The deletion can occur de novo, meaning it is a new mutation in the affected individual, or it can be inherited in an autosomal dominant manner if a parent carries a balanced translocation.

Clinical Features
Individuals with 13q deletion syndrome may present with a range of clinical features, which can include:
- Developmental delay and intellectual disability
- Craniofacial abnormalities, such as microcephaly and hypertelorism
- Congenital heart defects
- Skeletal abnormalities
- Growth retardation
- Ocular abnormalities, such as retinoblastoma
Diagnosis
Diagnosis of 13q deletion syndrome is typically made through genetic testing, such as karyotyping or chromosomal microarray analysis, which can identify the specific deletion on chromosome 13. Prenatal diagnosis may be possible if there is a known risk, such as a parent with a balanced translocation.
Management
Management of 13q deletion syndrome is symptomatic and supportive. It may involve:
- Early intervention programs for developmental delays
- Surgical correction of congenital anomalies
- Regular monitoring for potential complications, such as retinoblastoma
- Genetic counseling for affected families
Prognosis
The prognosis for individuals with 13q deletion syndrome varies widely depending on the size and location of the deletion and the specific symptoms present. Early intervention and supportive care can improve outcomes for many affected individuals.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian